EP Patent

EP3845221A1 — Solid state forms of sofosbuvir

Assigned to Teva Pharmaceuticals International GmbH · Expires 2021-07-07 · 5y expired

What this patent protects

The present disclosure encompasses solid state forms of Sofosbuvir, processes for their production, and pharmaceutical compositions thereof.

USPTO Abstract

The present disclosure encompasses solid state forms of Sofosbuvir, processes for their production, and pharmaceutical compositions thereof.

Drugs covered by this patent

Patent Metadata

Patent number: EP3845221A1
Jurisdiction: EP
Classification: —
Expires: 2021-07-07
Drug substance claim: No
Drug product claim: No
Assignee: Teva Pharmaceuticals International GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.